Individuals with type 2 diabetes (T2D) who develop cancer are more likely to die in the following seven years if they are smokers or physically inactive, according to a new study of more than half a million people being presented ...
Sep 19, 2022
0
29
New research from Yale Cancer Center reveals a higher risk of cancer mortality in incarcerated adults, as well as among those diagnosed with cancer in the first year after release from prison.
Sep 16, 2022
0
6
New research offers yet another reason why Americans should cut back on their soda consumption: Drinking too many sugary beverages may increase the risk of death from cancer.
Sep 15, 2022
0
49
New research published in Science Advances today conducted by researchers at Peter MacCallum Cancer Center show a new treatment for two challenging blood cancers could potentially help more patients than originally thought.
Sep 15, 2022
0
38
New long-term use of opioids to quell pain after lung cancer surgery is linked to a 40% heightened risk of death from any cause within the next 2 years, finds research published online in the journal Regional Anesthesia & ...
Sep 12, 2022
0
87
Older adults who participate weekly in many different types of leisure time activities, such as walking for exercise, jogging, swimming laps, or playing tennis, may have a lower risk of death from any cause, as well as death ...
Aug 24, 2022
0
87
A new study led by researchers at the American Cancer Society (ACS) reports nearly 123,000 cancer deaths, or close to 30 percent of all cancer deaths, were from cigarette smoking in the United States in 2019, leading to more ...
Aug 10, 2022
0
18
Melanopsin (OPN4) is a light-sensing protein found in skin and retina cells. A new study conducted at the University of São Paulo (USP) in Brazil suggests that OPN4 can also participate in the development and progression ...
Aug 9, 2022
0
68
A research team at the University of Oklahoma published a study in the journal Advanced Science that presents a new approach to triggering an adaptive immune response.
Aug 9, 2022
0
34
Sometimes too much of a good thing is not good at all. Inhibiting the function of the PD-1 protein, which blocks immune function, has shown high therapeutic efficacy in cancer immunotherapy. However, when this function is ...
Aug 9, 2022
0
2
